by The U.S. Food and Drug Administration has approved the French drugmaker Ipsen’s medication Iqirvo (elafibranor). Doctors discuss what this means for liver disease patients.The U.S. Food and Drug Administration has approved the French drugmaker Ipsen’s medication Iqirvo (elafibranor). Doctors discuss what this means for liver disease patients.Read More27748a8e-dd4d-5de3-a75f-52fd3c9bb492, fox-news/health, fox-news/health/healthy-living/medications, fox-news/health/medical-research, fox-news/health/healthy-living/health-care, fox-news/health/medical-research/rare-diseases, fox-news/lifestyle, fox-news/health/sleep-disorders/fatigue, fnc, fox-news/health, article, Fox News, Amy McGorryFOX News : Health
